Calmare Therapeutics Inc (fka CTTC)

[powderbum]

That trial is probably going to be worth a billion dollars when completed and the outcome is certain. They only need 20% efficacy. Calmare is usally around 80% effiay.How do biotech companies raise big money for phase 3 studies when they have no current profits? It's all about future expectations of revenues. We should have NO Problem raising the money.